Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ClearPoint Neuro, Inc. Director's Dealing 2012

Feb 27, 2012

32641_dirs_2012-02-27_28ede1b3-e8cc-4fcf-b39e-50f1522877ec.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: MRI INTERVENTIONS, INC. (NONE)
CIK: 0001285550
Period of Report: 2012-02-27

Reporting Person: PIETRANGELO MICHAEL (Director)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 48263 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Warrants (right to buy) $0.01 2013-09-14 Common Stock (25000) Direct
Option (right to buy) $1.80 2020-12-13 Common Stock (38000) Direct
Option (right to buy) $1.80 2020-12-13 Common Stock (12000) Direct

Footnotes

F1: The shares subject to this warrant are immediately exercisable.

F2: One-third of the shares subject to this option vested on the first anniversary of the grant date, December 13, 2011. The remaining shares subject to this option vest ratably on the second and third anniversaries of the grant date, December 13, 2012 and December 13, 2013.

F3: The shares subject to this option vest ratably on the first, second and third anniversaries of the grant date, December 13, 2011, December 13, 2012 and December 13, 2013, provided that no shares vest until such time as the company closes a target equity financing, which is defined as one or more equity financing transactions that results in cumulative gross proceeds of at least $10 million.